<DOC>
	<DOCNO>NCT00685906</DOCNO>
	<brief_summary>The purpose study examine effect co-administration AZD6140 Nordette® blood level certain female hormone .</brief_summary>
	<brief_title>AZD6140 Oral Contraceptive Interaction Study</brief_title>
	<detailed_description />
	<mesh_term>Ethinyl Estradiol</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Levonorgestrel</mesh_term>
	<mesh_term>Ethinyl Estradiol-Norgestrel Combination</mesh_term>
	<mesh_term>Ethinyl estradiol , levonorgestrel drug combination</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Females healthy , nonpregnant , plan pregnancy within study period , nonbreastfeeding , premenopausal Either currently take Nordette® well tolerate least two month prior randomisation history breakthrough bleeding , , willing take Nordette 2 month prior receive study drug Females childbearing potential must willing use least 1 additional medically approve nonhormonal barrier contraceptive method ( example , condom diaphragm ) contain spermicide History intolerance ( e.g . adverse event ) oral contraceptive AZD6140 History blood vessel bleeding condition would make volunteer prone bleed History presence significant medical problem Women current smoker</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>oral contraceptive</keyword>
	<keyword>birth control</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>